https://www.escmid.org/congress-events/escmid-global/
ESCMID: ESCMID Global
ESCMID Global (formerly ECCMID): an annual congress bringing together experts and specialists in Clinical Microbiology and Infectious Diseases.
escmid global
https://www.prnewswire.com/news-releases/escmid-global-maternal-rsv-vaccination-cuts-infant-hospitalisation-risk-by-over-80-major-ukhsa-study-finds-302740834.html
ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA...
/PRNewswire/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory...
escmid globalrsv vaccinationmaternalcutsinfant
https://lifestyle.kotaradio.com/story/176125/seegene-introduces-stagora-at-escmid-global-2026-highlighting-real-time-data-with-automated-pcr-workflows/
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR...
real time dataescmid globalintroduceshighlightingautomated
https://www.jmilabs.com/events/escmid-global-2025/
ESCMID Global 2025 - JMI Laboratories
escmid globaljmilaboratories
https://www.pharmaceutical-technology.com/analyst-comment/escmid-global-2026-adibelivir-emerges-as-potential-disease-modifying-therapy-for-hsv/
ESCMID Global 2026: Adibelivir emerges as potential disease-modifying therapy for HSV -...
Apr 23, 2026 - Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical trials.
escmid globalemergespotentialdiseasemodifying
https://lifestyle.q923radio.com/story/154517/escmid-global-2026-shionogi-presents-new-real-world-data-highlighting-clinical-effectiveness-of-fetroja-fetcroja-cefiderocol-in-mbl-producing-enterobacterales-infections/
ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of...
real world dataescmid globalclinical effectivenesspresentsnew
https://nanoporetech.com/ja/about/events/conferences/escmid-2026
Oxford Nanopore at ESCMID Global 2026
Oxford Nanopore Technologies are exhibiting and presenting at ESCMID Global in April.
oxford nanoporeescmid global
https://www.ttp.com/events/escmid-global-2025
ESCMID Global 2025 - TTP
Join TTP at ESCMID Global 2025, Stand G1, to explore the future of diagnostics. Meet our experts and discover innovative lab-quality diagnostic solutions....
escmid globalttp
https://www.hitachi-hightech.com/eu/en/events/escmid-global-2025.html
ESCMID Global : Hitachi High-Tech in Europa
Join ESCMID Global, April 11-15. Visit Booth C101 to discover Hitachi's cutting-edge electron microscopes and ion beam systems.
escmid globalhigh techin europahitachi
https://www.clinicaltrialsarena.com/analyst-comment/escmid-global-2025-challenges-eliminating-viral-hepatitis/
ESCMID Global 2025: The challenges of eliminating viral hepatitis
Apr 17, 2025 - At the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, held from April 11-15, the...
escmid globalthe challengesviral hepatitiseliminating
https://www.selectscience.net/article/gradientech-at-escmid-global-2025
Gradientech at ESCMID Global 2025
Gradientech showcases new QuickMIC clinical data and innovations at ESCMID Global 2025
escmid global
https://www.sahmcapital.com/news/content/enanta-to-present-phase-2b-zelicapavir-rsv-trial-data-at-escmid-global-2026-2026-04-07
Enanta to present Phase 2b zelicapavir RSV trial data at ESCMID Global 2026
Enanta outlined upcoming ESCMID Global 2026 presentations on zelicapavir, an oral once-daily RSV drug candidate, with data scheduled for April 18, 2026. One...
to presentescmid globalphasersvtrial